Stocks
Sarepta Therapeutics (SRPT) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -652.7 | -453.4 | -306.1 | -582.1 | -439.2 | 153.4 | ||
| Changes by years, y/y, % | +90% | -31% | -32% | +90% | -25% | +5.1% | |||
Sarepta Therapeutics. EBITDA US GAAP, bln rub
Sarepta Therapeutics. EBITDA US GAAP, changes, %
Sarepta Therapeutics. EBITDA US GAAP, sum by quarters, bln rub
Sarepta Therapeutics (SRPT) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA, bln rub | ? | -20.8 | 60.8 | 58.3 | 12.0 | 22.2 | 153.4 | |
| Changes by years, y/y, % | -81% | -175% | -154% | -112% | -206% | |||
| Changes by quarters, q/q, % | -79% | -392% | -4% | -79% | +85% | |||
